UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Drug Free Solution, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   333-175525   99-0365611

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

 

531 Main St. # 670

El Segundo, CA 90245

(Current Address of Principal Executive Offices)

 

Common Stock, $0.001 par value per share

(Title of each class of securities covered by this Form)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1) [X]
  Rule 12g-4(a)(2) -
  Rule 12h-3(b)(1)(i) [X]
  Rule 12h-3(b)(1)(ii) -
  Rule 15d-6 [X]

 

Approximate number of holders of record as of the certification or notice date:

Common Stock: Two Hundred Sixty-Eight (268)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Drug Free Solution, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: April 25, 2019 Drug Free Solution, Inc.
     
  By : /s/ Genie O’Malley.
  Name: Genie O’Malley
  Title: President

 

 

 

     

 

 

Drug Free Solutions (PK) (USOTC:DSOL)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Drug Free Solutions (PK)
Drug Free Solutions (PK) (USOTC:DSOL)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Drug Free Solutions (PK)